From the *Texas Back Institute/Texas Health Research Institute, Plano, TX; †The Spine Institute at Saint John's Health Center, Santa Monica, CA; ‡Hospital for Joint Diseases, New York, NY; §CORE Orthopaedic Medical Center, Encinitas, CA; ∥Texas Spine and Joint Hospital, Tyler, TX; ¶Haider Spine Center Medical Clinic, Inc., Riverside, CA; #Hospital for Special Surgery, New York, NY; **St. Mary's Spine Center, San Francisco, CA; †† Pennsylvania Hospital, Philadelphia, PA; ‡‡Orthopedic Spine Associates, LLC, Eugene, OR; §§Semmes-Murphey Neurological & Spine Institute, Methodist University Hospital, University of Tennessee, Memphis, TN; ∥∥LA Spine Surgery Institute, Los Angeles, CA; ¶¶University of California at San Francisco, San Francisco, CA; ##Yale University, New Haven, CT; ***SUNY Syracuse, Syracuse, NY; †††William Beaumont Hospital, Royal Oak, MI; ‡‡‡Michigan Brain & Spine Institute PC, MI Orthopaedic Center, Ypsilanti, MI; and §§§New York University Medical Center/Hospital for Joint Diseases Spine Center, New York, NY.
Acknowledgment date: August 7, 2006. First revision date: September 22, 2006. Acceptance date: October 23, 2006.
The device(s)/drug(s) that is/are the subject of this manuscript is/are being evaluated as part of an ongoing FDA-approved investigational protocol (IDE) or corresponding national protocol.
No funds were received in support of this work. One or more of the author(s) has/have received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this manuscript: e.g., honoraria, gifts, consultancies.
Address correspondence and reprint requests to Jack Zigler, MD, Texas Back Institute/Texas Health Research Institute, Suite 200, 6020 W. Parker Road, Plano, TX 75093; E-mail: [email protected]
